Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BrainMet ADePPT
NCT06807619Phase 1Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jan 2025
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sotorasib in brain tumor (2 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Overall Response Rate at 1 year. Started Jan 2025; status: recruiting.
02
Drugs
sotorasib
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT06807619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06807619.